Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans

Gender Medicine - Tập 5 - Trang 44-52 - 2008
Joseph Leung1, Muthuvel Jayachandran1, June Kendall-Thomas1, Thomas Behrenbeck2, Philip Araoz3, Virginia M. Miller1
1Departments of Surgery, Physiology, and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota
2Internal Medicine, Division of Cardiology, Mayo Clinic College of Medicine, Rochester, Minnesota
3Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota

Tài liệu tham khảo

Hayes, 1998, Human vascular smooth muscle cells express receptors for CC chemokines, Arterioscler Thromb Vasc Biol, 18, 397, 10.1161/01.ATV.18.3.397 Wick, 1995, Is atherosclerosis an immunologically mediated disease?, Immunol Today, 16, 27, 10.1016/0167-5699(95)80067-0 Haraoka, 1995, Participation of Tlymphocytes in atherogenesis: Sequential and quantitative observation of aortic lesions of rats with dietinduced hypercholesterolaemia using en face double immunostaining, Virchows Arch, 426, 307, 10.1007/BF00191369 Watanabe, 1995, T lymphocytes in atherosclerotic lesions, Ann N Y Acad Sci., 748, 40, 10.1111/j.1749-6632.1994.tb17307.x Ross, 1976, Glomset JA, The pathogenesis of atherosclerosis (second of two parts). N Engl J Med, 295, 420 Pawlak, 2005, Mysliwiec M, Circulating betachemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients - role of oxidative stress. Cytokine, 31, 18 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Sheikine, 2004, Hansson GK, Chemokines and atherosclerosis. Ann Med, 36, 98 Mause, 2005, Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium, Arterioscler Thromb Vasc Biol, 25, 1512, 10.1161/01.ATV.0000170133.43608.37 Eriksson, 2004, Mechanisms of leukocyte recruitment to atherosclerotic lesions: Future prospects, Curr Opin Lipidol., 15, 553, 10.1097/00041433-200410000-00009 Kher, 2004, Marsh JD, Pathobiology of atherosclerosis— a brief review. Semin Thromb Hemost, 30, 665, 10.1055/s-2004-861509 Schall, 1994, Chemokines, leukocyte trafficking, and inflammation, Curr Opin Immunol, 6, 865, 10.1016/0952-7915(94)90006-X Schall, 1991, Biology of the RANTES/SIS cytokine family, Cytokine, 3, 165, 10.1016/1043-4666(91)90013-4 Furie, 1995, Randolph GJ, Chemokines and tissue injury. Am J Pathol, 146, 1287 Strieter, 1994, The immunopathology of chemotactic cytokines: The role of interleukin-8 and monocyte chemoattractant protein-1, J Lab Clin Med, 123, 183 Kobusiak-Prokopowicz, 2005, Kinetics of chemokines in acute myocardial infarction, Kardiol Pol, 62, 301 Ferroni, 2003, Platelet activation, inflammatory mediators and hypercholesterolemia, Curr Vasc Pharmacol Sin, 1, 157, 10.2174/1570161033476772 Sun, 2005, Chemokine RANTES is upregulated in monocytes from patients with hyperhomocysteinemia, Acta Pharmacol Sin, 26, 1317, 10.1111/j.1745-7254.2005.00178.x Ridker, 2005, C-reactive protein, inflammation, and cardiovascular disease, Clinical update. Tex Heart Inst J, 32, 384 Miller, 2007, McConnell JP, Use of BNP and CRP as biomarkers in assessing cardiovascular disease: Diagnosis versus risk. Curr Vasc Pharmacol, 5, 15 2002 Shaw, 2006, Insights from the NHLBI-sponsored Women′s Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies, J Am Coll Cardiol, 47, S4, 10.1016/j.jacc.2005.01.072 Agatston, 1990, Quantification of coronary artery calcium using ultrafast computed tomography, J Am Coll Cardiol, 15, 827, 10.1016/0735-1097(90)90282-T Rumberger, 1999, Kondos G, Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons [published correction appears in Mayo Clin Proc. 1999;74:538]. Mayo Clin Proc, 74, 243 Kottke, 1991, Levels of lipids, lipoproteins, and apolipoproteins in a defined population, Mayo Clin Proc, 66, 1198, 10.1016/S0025-6196(12)62470-7 Maher, 1996, Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis, Am J Epidemiol, 144, 943, 10.1093/oxfordjournals.aje.a008864 Peyser, 2002, Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults, Circulation, 106, 304, 10.1161/01.CIR.0000022664.21832.5D Barrett-Connor, 1991, Bush TL, Estrogen and coronary heart disease in women. JAMA, 265, 1861 Bracamonte, 2002, Ovariectomy increases mitogens and plateletinduced proliferation of arterial smooth muscle, Am J Physiol Heart Circ Physiol, 283, H853, 10.1152/ajpheart.00201.2002 Jayachandran, 2005, Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation and secretion in platelets, Am J Physiol Heart Circ Physiol, 288, H2355, 10.1152/ajpheart.01108.2004 Harman, 2005, KEEPS: The Kronos Early Estrogen Prevention Study, Climacteric, 8, 3, 10.1080/13697130500042417 Kanda, 2003, Watanabe S, 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol, 120, 420 Hecht, 2006, Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment, Am Heart J, 151, 1139, 10.1016/j.ahj.2005.07.018 Giachelli, 2004, Vascular calcification mechanisms, J Am Soc Nephrol, 15, 2959, 10.1097/01.ASN.0000145894.57533.C4 Shioi, 1995, Betaglycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 15, 2003, 10.1161/01.ATV.15.11.2003 Tintut, 1998, cAMP stimulates osteoblast-like differentiation of calcifying vascular cells, Potential signaling pathway for vascular calcification. J Biol Chem, 273, 7547